Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    01-March-2001      
Issue 60 * Next Update - 14:00 UTC 08:00 EST    02-March-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 01-March-2001:

The following stories appear in full on Today's Vidyya Medical News Service Web site.

Although there is a huge body of scientific research on cancer biology, the quality and quantity of research on the management of cancer pain lags far behind, according to researchers at the New England Medical Center Evidence-based Practice Center (EPC) conducting a systematic literature review for the Agency for Healthcare Research and Quality (AHRQ). Overall, the EPC found that the solid evidence that exists on specific therapies such as anti-inflammatory drugs or opioids is overshadowed by inadequate guidance on more complex choices now expected of front-line clinicians.

For more information: Surprisingly Large Gaps Found In Cancer Pain Research

An evidence report in today's Vidyya is a literature synthesis and not a clinical practice guideline or a survey of current practice. It is intended to provide background information and summaries of evidence for use by varied groups, including primary care practitioners, nurses, pharmacists, physical therapists, specialists in oncology, pain treatment, or other disciplines, as well as policy makers. We reviewed the published literature on the epidemiology of cancer pain and its relief and also summarized predominantly randomized controlled trials so as to gauge the efficacy of major treatments.

For more information: Evidence Report/Technology Assessment: Management Of Cancer Pain

Aricept is the #1 prescribed Alzheimer's medication worldwide with more than 450 million days of patient use; more than 1.4 million people in the United States alone have begun Aricept therapy.

For more information: Facts About Aricept ® (Donepezil Hydrochloride) For The Treatment Of Mild-To-Moderate Alzheimer's Disease

Once-daily Aricept (donepezil HCl) has been clinically proven to treat the symptoms of mild to moderate AD. In people who respond, symptoms may get better, stay the same, or progress at a slower rate. Get the full prescribing issue in today's issue.

For more information: Prescribing Information: Aricept

South African researchers may have found a simple and effective way of tackling dangerous infections - garlic. The Child's Health Institute in Cape Town has found that garlic has antifungal and antibiotic powers.

For more information: Garlic For Childhood Infections?

Today's Vidyya articles are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.